Ductal closure with paracetamol: A surprising new approach to patent ductus arteriosus treatment

Pediatrics

Volumn 128, Issue 6, 2011, Pages

  Hammerman, Cathy ^a,b   Bin Nun, Alona ^a   Markovitch, Einat ^a   Schimmel, Michael S ^a,b   Kaplan, Michael ^a,b   Fink, Daniel ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Ibuprofen; Paracetamol; Patent ductus arteriosus

Indexed keywords

ACAMOLI; IBUPROFEN; PARACETAMOL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; DRUG CONTRAINDICATION; DRUG RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL;

ACETAMINOPHEN; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE;

EID: 83155192881     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0359     Document Type: Article

References (15)

1. Zecca E, Romagnoli C, De Carolis M, Costa S, Marra R, De Luca D. Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics. 2009;124(2):480-484
2. Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr. 2009;98(1):36-42
3. Poon G. Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus. Proc (Bayl Univ Med Cent). 2007;20(1):83-85
4. Grèen K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by paracetamol. Prostaglandins. 1989;37(3):311-315
5. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J. 2005;19(6):635-637
6. Kulmacz RJ, Wang LH. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem. 1995;270(41):24019-24023
7. Momma K, Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol. 1990;162(5):1304-1310
8. Peterson RG. Consequences associated with nonnarcotic analgesics in the fetus and newborn. Fed Proc. 1985;44(7):2309-2313
9. Simbi KA, Secchieri S, Rinaldo M, Demi M, Zanardo V. In utero ductal closure following near-term maternal self-medication with nimesulide and acetaminophen. J Obstet Gynaecol. 2002;22(4):440-445
10. Agrawal S, Fitzsimons JJ, Horn V, Petros A. Intravenous paracetamol for postoperative analgesia in a 4-day-old term neonate. Paediatr Anaesth. 2007;17(1):70-71
11. Wilson-Smith EM, Morton NS. Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists. Paediatr Anaesth. 2009;19(4):329-337
12. Jacqz-Aigrain E, Anderson BJ. Pain control: non-steroidal anti-inflammatory agents. Semin Fetal Neonatal Med. 2006;11(4):251-259
13. Anderson BJ, Allegaert K. Intravenous neonatal paracetamol dosing: the magic of 10 days. Paediatr Anaesth. 2009;19(4):289-295
14. Accepted for publication Jul 20, 2011
15. Moll M, Goelz R, Naegele T, Wilke M, Poets CF. Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology. 2011;99(2):90-94